Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. markets open in 7 hours 4 minutes

S&P Futures
5,912.00
+15.50(+0.26%)
Dow Futures
43,574.00
+6.00(+0.01%)
Nasdaq Futures
20,638.75
+145.00(+0.71%)
Russell 2000 Futures
2,320.40
+6.80(+0.29%)
Crude Oil
67.07
+0.05(+0.07%)
Gold
2,589.00
+18.90(+0.74%)

Mainz Biomed N.V. (MYNZ)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

0.2387

-0.0113

(-4.52%)

At close: 04:00PM EST

0.2399

+0.00

(+0.50%)

After hours:

07:58PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	15.29M
Enterprise Value	22.58M
Trailing P/E	N/A
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	5.21
Price/Book (mrq)	1.71
Enterprise Value/Revenue	24.62
Enterprise Value/EBITDA	-2.84

Trading Information

Stock Price History

Beta (5Y Monthly)	0.08
52-Week Change ³	-79.40%
S&P500 52-Week Change ³	29.10%
52 Week High ³	1.7900
52 Week Low ³	0.1850
50-Day Moving Average ³	0.2694
200-Day Moving Average ³	0.5878

Share Statistics

Avg Vol (3 month) ³	3.17M
Avg Vol (10 day) ³	7.78M
Shares Outstanding ⁵	64.04M
Implied Shares Outstanding ⁶	64.04M
Float ⁸	22.09M
% Held by Insiders ¹	20.22%
% Held by Institutions ¹	0.88%
Shares Short (Oct 31, 2024) ⁴	1.52M
Short Ratio (Oct 31, 2024) ⁴	0.61
Short % of Float (Oct 31, 2024) ⁴	6.87%
Short % of Shares Outstanding (Oct 31, 2024) ⁴	5.93%
Shares Short (prior month Sep 30, 2024) ⁴	2.27M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	0.00%
Operating Margin (ttm)	-1,883.22%

Management Effectiveness

Return on Assets (ttm)	-99.24%
Return on Equity (ttm)	-4,333.71%

Income Statement

Revenue (ttm)	917.2k
Revenue Per Share (ttm)	0.05
Quarterly Revenue Growth (yoy)	4.60%
Gross Profit (ttm)	N/A
EBITDA	-21.59M
Net Income Avi to Common (ttm)	-22.51M
Diluted EPS (ttm)	-1.1100
Quarterly Earnings Growth (yoy)	N/A

Balance Sheet

Total Cash (mrq)	977.76k
Total Cash Per Share (mrq)	0.04
Total Debt (mrq)	8.27M
Total Debt/Equity (mrq)	N/A
Current Ratio (mrq)	0.24
Book Value Per Share (mrq)	-0.16

Cash Flow Statement

Operating Cash Flow (ttm)	-19.31M
Levered Free Cash Flow (ttm)	-12.58M